The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...
Zacks Investment Research on MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $15.24, moving -5.28% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.28%.
Zacks Investment Research on MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know
In the latest close session, Ginkgo Bioworks Holdings, Inc. (DNA) was up +1.06% at $16.14. The stock's change was more than the S&P 500's daily gain of 0.01%. On the other hand, the Dow registered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback